Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 26501-26550 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06831929
HPV Ends Here: Increasing Uptake of the HPV Vaccine
NA
Recruiting
2,232 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06201676
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
PHASE4
Recruiting
458 participants
Started: Feb 28, 2025 · Completed: Aug 31, 2027
2 conditions
2 sponsors
2 locations
NCT06812988
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
PHASE2
Recruiting
84 participants
Started: Feb 28, 2025 · Completed: Sep 13, 2028
1 condition
1 sponsor
23 locations
NCT06764316
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
PHASE1
Recruiting
148 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2033
1 condition
1 sponsor
10 locations
NCT06778863
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
PHASE1
Recruiting
90 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2028
11 conditions
1 sponsor
15 locations
NCT06768476
CART123 + Ruxolitinib in Relapsed/Refractory AML
PHASE1
Recruiting
12 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2045
2 conditions
2 sponsors
1 location
NCT06673043
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
N/A
Recruiting
100 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2028
1 condition
1 sponsor
11 locations
NCT06852209
Training Cognition With Neurofeedback After Stroke
NA
Recruiting
20 participants
Started: Feb 28, 2025 · Completed: Nov 28, 2026
2 conditions
1 sponsor
1 location
NCT06923371
Moms and Babies Health and Well-being
NA
Recruiting
1,250 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT06724289
Psilocybin for Prolonged Grief Disorder
EARLY_PHASE1
Not yet recruiting
12 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT06218069
Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor
PHASE2/PHASE3
Not yet recruiting
20 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2027
1 condition
4 sponsors
2 locations
NCT06240897
CURATE.Dtx as a Diagnostic and Management Tool for Delirium
NA
Not yet recruiting
20 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2026
1 condition
3 sponsors
1 location
NCT06395688
Drug-Drug Interaction Between THC and AEF0117
PHASE1
Not yet recruiting
24 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2025
1 condition
2 sponsors
0 locations
NCT06858696
A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function
PHASE1
Recruiting
48 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2026
1 condition
1 sponsor
4 locations
NCT06942416
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
PHASE2
Recruiting
36 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT06610266
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
PHASE4
Recruiting
400 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT06919419
HOTSPOT Study: Implement and Evaluate the PrEP Implementation Strategy
N/A
Recruiting
3,600 participants
Started: Feb 28, 2025 · Completed: Mar 1, 2029
3 conditions
2 sponsors
1 location
NCT05917665
Early Digital, Analyte and Neurologic Biomarkers of Acute and Chronic Brain Injury and Recovery in CQT Instructors
N/A
Enrolling by invitation
300 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05920720
Self-Guided Personalized Treatment for Women
NA
Not yet recruiting
50 participants
Started: Feb 28, 2025 · Completed: Aug 15, 2025
1 condition
2 sponsors
1 location
NCT06700694
Technology-Assisted Early Mobilization Program Among Patients in the Intensive Care Units
NA
Not yet recruiting
138 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2027
1 condition
3 sponsors
0 locations
NCT06702280
Assessing the Safety of an IGY Supplement on the Gut Microbiome
PHASE1
Not yet recruiting
20 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2025
2 conditions
2 sponsors
1 location
NCT06671548
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
PHASE3
Recruiting
120 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2027
2 conditions
1 sponsor
1 location
NCT06732583
A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years
PHASE1
Not yet recruiting
36 participants
Started: Feb 28, 2025 · Completed: Aug 31, 2025
1 condition
2 sponsors
0 locations
NCT06831149
Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
PHASE2
Recruiting
225 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2030
2 conditions
1 sponsor
1 location
NCT06576115
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
PHASE2
Recruiting
30 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT06218732
Revealing Engagement Dynamics Among Semantic Dementia Patients
N/A
Not yet recruiting
500 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT06712043
Testing a Tailored Home Exercise Program to Reduce Pain and Fatigue in Patients with FSHD.
NA
Not yet recruiting
50 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2025
1 condition
2 sponsors
0 locations
NCT06829797
A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined with SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
PHASE2
Not yet recruiting
96 participants
Started: Feb 28, 2025 · Completed: Feb 29, 2028
1 condition
1 sponsor
0 locations
NCT06829693
Evaluation of the Incidence of Psychiatric Disorders As a Function of First-line Antiepileptic Drug Prescribing Practices: Use of Assurance Maladie Databases
N/A
Not yet recruiting
355,000 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
2 conditions
3 sponsors
1 location
NCT06835179
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.
PHASE2
Not yet recruiting
28 participants
Started: Feb 28, 2025 · Completed: May 31, 2027
3 conditions
1 sponsor
0 locations
NCT06783062
Activation Failure of Knee Extensors After Anterior Cruciate Ligament Rupture Depending on the Contraction Mode
N/A
Not yet recruiting
60 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2027
3 conditions
2 sponsors
0 locations
NCT06750341
Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol
PHASE2
Not yet recruiting
156 participants
Started: Feb 28, 2025 · Completed: Sep 30, 2026
1 condition
1 sponsor
0 locations
NCT06489262
"Efficacy Trial of Healthy Together (Juntos)"
NA
Recruiting
750 participants
Started: Feb 28, 2025 · Completed: May 31, 2029
3 conditions
2 sponsors
1 location
NCT06833216
Familial Breast Cancer in China
N/A
Not yet recruiting
500 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2035
2 conditions
1 sponsor
1 location
NCT06674083
Reliability of the Gyko Inertial Sensor System in Evaluating Jumping and Postural Stability Parameters in Healthy Adults
N/A
Not yet recruiting
55 participants
Started: Feb 28, 2025 · Completed: May 31, 2025
2 conditions
1 sponsor
0 locations
NCT06815042
The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy
PHASE4
Not yet recruiting
30 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06830668
Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation
PHASE4
Not yet recruiting
250 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06791772
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
PHASE2
Not yet recruiting
150 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT06833827
'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL
NA
Recruiting
111 participants
Started: Feb 28, 2025 · Completed: Jan 31, 2029
1 condition
4 sponsors
1 location
NCT06784206
Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer
PHASE2
Not yet recruiting
30 participants
Started: Feb 28, 2025 · Completed: Jan 31, 2028
3 conditions
1 sponsor
1 location
NCT06744998
Hemopatch Implication After Axillary Dissection for Breast Cancer
NA
Not yet recruiting
190 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06570291
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
PHASE3
Recruiting
520 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2028
1 condition
1 sponsor
2 locations
NCT05869825
HFNC vs NIPPV Following Extubation
NA
Recruiting
200 participants
Started: Feb 27, 2025 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT06834334
Clinical Effectiveness of Advanced Hybrid Closed-loop Systems for Achieving Time in Tight Range Among T1D Patients
N/A
Recruiting
189 participants
Started: Feb 27, 2025 · Completed: Dec 31, 2025
1 condition
3 sponsors
3 locations
NCT06830343
The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
PHASE1
Recruiting
66 participants
Started: Feb 27, 2025 · Completed: Oct 1, 2026
1 condition
1 sponsor
1 location
NCT06678737
CBIT+TMS R33 Phase
PHASE2
Recruiting
60 participants
Started: Feb 27, 2025 · Completed: Jul 15, 2030
2 conditions
1 sponsor
1 location
NCT06800755
Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and Pruritus
NA
Recruiting
40 participants
Started: Feb 27, 2025 · Completed: Jul 4, 2025
3 conditions
1 sponsor
1 location
NCT06236607
Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
NA
Recruiting
140 participants
Started: Feb 27, 2025 · Completed: Jun 30, 2027
2 conditions
2 sponsors
2 locations
NCT06561087
Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions
PHASE2
Recruiting
45 participants
Started: Feb 27, 2025 · Completed: May 30, 2029
1 condition
1 sponsor
1 location
NCT06936852
Ultrasound Guided Serratus Posterior Superior Intercostal Plane Versus PECS II Block In Breast Surgeries
NA
Active, not recruiting
50 participants
Started: Feb 27, 2025 · Completed: Aug 20, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
528
529
530
531
532
533
534
More pages
2369
Next